- Home
- About
- Find staff
- Manuela Terrinoni
Manuela Terrinoni
Postdoctor
Department of Microbiology and Immunology-
A thermostable, dry formulation inactivated Hikojima whole cell/cholera toxin B subunit oral cholera
vaccine
Manuela Terrinoni, Stefan Nordqvist, Madeleine Löfstrand, Frida Nilsson, Susanne Källgård, T. Sharma, Michael Lebens, Jan Holmgren
Vaccine - 2023 -
Characterization of the ganglioside recognition profile of Escherichia coli heat-labile enterotoxin
LT-IIc
Dani Zalem, Martin Juhas, Manuela Terrinoni, N. King-Lyons, Michael Lebens, A. Varrot, T. D. Connell, Susann Teneberg
Glycobiology - 2022 -
Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus
erythematosus
I. Yao Mattisson, S. Rattik, H. Björkbacka, I. Ljungcrantz, Manuela Terrinoni, Michael Lebens, Jan Holmgren, G. N. Fredrikson, B. Gullstrand, A. A. Bengtsson, J. Nilsson, M. Wigren
Vascular Pharmacology - 2021 -
Requirement for Cyclic AMP/Protein Kinase A-Dependent Canonical NF kappa B Signaling in the Adjuvant Action of Cholera Toxin and Its Non-toxic Derivative
mmCT
Manuela Terrinoni, Jan Holmgren, Michael Lebens, Maximilian Larena
Frontiers in Immunology - 2019 -
Proteomic analysis of cholera toxin adjuvant-stimulated human monocytes identifies Thrombospondin-1 and Integrin-beta 1 as strongly upregulated molecules involved in adjuvant
activity
Manuela Terrinoni, Jan Holmgren, Michael Lebens, Maximilian Larena
Scientific Reports - 2019 -
Novel approaches to mucosal vaccine development Strategies in vaccine antigen production, construction of a novel mucosal adjuvant and studies of its mode of
action
Manuela Terrinoni
2019 -
A Novel Nonantibiotic, lgt-Based Selection System for Stable Maintenance of Expression Vectors in Escherichia coli and Vibrio
cholerae
Manuela Terrinoni, Stefan Nordqvist, Susanne Källgård, Jan Holmgren, Michael Lebens
Applied and Environmental Microbiology - 2018 -
B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient
mice
S. Rattik, P. T. Mantani, I. Y. Mattisson, I. Ljungcrantz, L. Sundius, H. Bjorkbacka, Manuela Terrinoni, Michael Lebens, Jan Holmgren, J. Nilsson, M. Wigren, G. N. Fredrikson
Vascular Pharmacology - 2018 -
Deficiency in calcium-binding protein S100A4 impairs the adjuvant action of cholera
toxin
Jiabin Sun, Jan Holmgren, Maximilian Larena, Manuela Terrinoni, Yu Fang, A. R. Bresnick, Xianghua Zhou
Frontiers in Immunology - 2017 -
Construction and preclinical evaluation of mmCT, a novel mutant cholera toxin adjuvant that can be efficiently produced in genetically manipulated Vibrio
cholerae
Michael Lebens, Manuela Terrinoni, Stefan L. Karlsson, Maximilian Larena, Tobias Gustafsson-Hedberg, Susanne Källgård, Erik Nygren, Jan Holmgren
Vaccine - 2016 -
Cholera toxin, and the related nontoxic adjuvants mmCT and dmLT, promote human Th17 responses via cyclic AMP-protein kinase A and inflammasome-dependent IL-1
signaling
Maximilian Larena, Jan Holmgren, Michael Lebens, Manuela Terrinoni, Anna Lundgren
Journal of Immunology - 2015